These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 39279882)

  • 1. Protein Intake and High Uric Acid Stone Risk.
    Montgomery TA; Nair HR; Phadke M; Morhardt E; Ludvigson A; Motamedinia P; Singh D; Dahl NK
    Kidney Med; 2024 Sep; 6(9):100878. PubMed ID: 39279882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of metabolic parameters between pure-uric acid and mixed-uric acid kidney stone formers.
    Ricapito A; Gupta K; Zipkin J; Yim S; Connors C; Khargi R; Yaghoubian AJ; Khusid JA; Atallah WM; Gupta M
    World J Urol; 2024 Mar; 42(1):138. PubMed ID: 38478092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and biochemical profile of patients with "pure" uric acid nephrolithiasis compared with "pure" calcium oxalate stone formers.
    Negri AL; Spivacow R; Del Valle E; Pinduli I; Marino A; Fradinger E; Zanchetta JR
    Urol Res; 2007 Oct; 35(5):247-51. PubMed ID: 17786420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Temporal Changes in Kidney Stone Composition and in Risk Factors Predisposing to Stone Formation.
    Xu LHR; Adams-Huet B; Poindexter JR; Maalouf NM; Moe OW; Sakhaee K
    J Urol; 2017 Jun; 197(6):1465-1471. PubMed ID: 28111301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group.
    Prezioso D; Strazzullo P; Lotti T; Bianchi G; Borghi L; Caione P; Carini M; Caudarella R; Ferraro M; Gambaro G; Gelosa M; Guttilla A; Illiano E; Martino M; Meschi T; Messa P; Miano R; Napodano G; Nouvenne A; Rendina D; Rocco F; Rosa M; Sanseverino R; Salerno A; Spatafora S; Tasca A; Ticinesi A; Travaglini F; Trinchieri A; Vespasiani G; Zattoni F;
    Arch Ital Urol Androl; 2015 Jul; 87(2):105-20. PubMed ID: 26150027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 24-Hour Urinary Chemistries and Kidney Stone Risk.
    Ferraro PM; Taylor EN; Curhan GC
    Am J Kidney Dis; 2024 Aug; 84(2):164-169. PubMed ID: 38583757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pathophysiology, diagnosis and conservative therapy in calcium kidney calculi].
    Hess B
    Ther Umsch; 2003 Feb; 60(2):79-87. PubMed ID: 12649986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk Factors for Common Kidney Stones Are Correlated with Kidney Function Independent of Stone Composition.
    Simmons KE; Nair HR; Phadke M; Motamedinia P; Singh D; Montgomery TA; Dahl NK
    Am J Nephrol; 2023; 54(7-8):329-336. PubMed ID: 37253348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Uric Acid Nephrolithiasis: A Systemic Metabolic Disorder.
    Wiederkehr MR; Moe OW
    Clin Rev Bone Miner Metab; 2011 Dec; 9(3-4):207-217. PubMed ID: 25045326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of Urinary Inhibitor or Promoter Activity in Uric Acid Nephrolithiasis.
    Doizi S; Rodgers K; Poindexter J; Sakhaee K; Maalouf NM
    J Urol; 2016 Jun; 195(6):1799-804. PubMed ID: 26723865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal ammonium excretion after an acute acid load: blunted response in uric acid stone formers but not in patients with type 2 diabetes.
    Bobulescu IA; Maalouf NM; Capolongo G; Adams-Huet B; Rosenthal TR; Moe OW; Sakhaee K
    Am J Physiol Renal Physiol; 2013 Nov; 305(10):F1498-503. PubMed ID: 24026180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Case-control study of risk factors for idiopathic calcium nephrolithiasis.
    Wasserstein AG; Stolley PD; Soper KA; Goldfarb S; Maislin G; Agus Z
    Miner Electrolyte Metab; 1987; 13(2):85-95. PubMed ID: 3696092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Racial Differences in Risk Factors for Kidney Stone Formation.
    Zisman AL; Coe FL; Cohen AJ; Riedinger CB; Worcester EM
    Clin J Am Soc Nephrol; 2020 Aug; 15(8):1166-1173. PubMed ID: 32561654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dietetic and lifestyle recommendations for stone formers.
    Ferraro PM; Bargagli M
    Arch Esp Urol; 2021 Jan; 74(1):112-122. PubMed ID: 33459627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of BMI in nephrolithiasis in an Appalachian pediatric population: A single-center experience.
    Murphy MO; Erpelding SG; Chishti AS; Dugan A; Ziada A; Kiessling SG
    J Pediatr Urol; 2018 Aug; 14(4):330.e1-330.e8. PubMed ID: 29887297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Associations between Net Gastrointestinal Alkali Absorption, 24-Hour Urine Lithogenic Factors, and Kidney Stones.
    Ferraro PM; Taylor EN; Asplin JR; Curhan GC
    Clin J Am Soc Nephrol; 2023 Aug; 18(8):1068-1074. PubMed ID: 37256914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between body mass index and quantitative 24-hour urine chemistries in patients with nephrolithiasis.
    Eisner BH; Eisenberg ML; Stoller ML
    Urology; 2010 Jun; 75(6):1289-93. PubMed ID: 20018350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Age, Body Mass Index, and Gender Predict 24-Hour Urine Parameters in Recurrent Idiopathic Calcium Oxalate Stone Formers.
    Otto BJ; Bozorgmehri S; Kuo J; Canales M; Bird VG; Canales B
    J Endourol; 2017 Dec; 31(12):1335-1341. PubMed ID: 29084490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the metabolic profile of mixed calcium oxalate/uric acid stone formers to that of pure calcium oxalate and pure uric acid stone formers.
    Friedlander JI; Moreira DM; Hartman C; Elsamra SE; Smith AD; Okeke Z
    Urology; 2014 Aug; 84(2):289-94. PubMed ID: 24929942
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.